A Comparison of the Cost-Effectiveness of Almotriptan and Sumatriptan in the Treatment of Acute Migraine Using a Composite Efficacy/Tolerability End Point

OBJECTIVES: To use a composite efficacy/tolerability end point to compare the cost-effectiveness, from the perspective of a U.S. health care payer, of almotriptan and sumatriptan in the treatment of an acute migraine attack. METHODS: The composite end point .Sustained pain free and No Adverse Events...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Paul, Reeder, C. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2004
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438247/
https://www.ncbi.nlm.nih.gov/pubmed/15228377
http://dx.doi.org/10.18553/jmcp.2004.10.3.259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438247/
https://www.ncbi.nlm.nih.gov/pubmed/15228377
http://dx.doi.org/10.18553/jmcp.2004.10.3.259

Ejemplares similares